Reaction

Urine Analysis Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,970 reports · 62 co-occurring drugs

As of the last recalculation, Urine Analysis Abnormal appears in 2,970 FAERS reports alongside 62 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 97.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alemtuzumab	246	97.1	98.3
Dimenhydrinate	101	68.7	69.4
Dalfampridine	232	24.5	24.6
Methylprednisolone Sodium Succinate	112	17.5	17.6
Methylprednisolone	216	11.7	11.7
Oxybutynin	40	9.7	9.7
Cetirizine Hydrochloride Allergy	40	9.4	9.4
Cetirizine Hydrochloride Tablets	40	9.4	9.4
Baclofen	111	9.3	9.4
Oxybutynin Chloride	11	8.8	8.8
Ciprofloxacin Hydrochloride And Hydrocortisone	22	7.5	7.5
Cyanocobalamin	34	7.3	7.3
Amantadine	16	7.3	7.3
Acyclovir	111	7.0	7.0
Octreotide Acetate	30	6.9	6.9
Cladribine	9	6.6	6.6
Diphenhydramine Hydrochloride	144	6.3	6.4
Terazosin Hydrochloride	8	6.3	6.3
Lanreotide Acetate	7	6.3	6.3
Dronabinol	7	6.1	6.1
Ranitidine	162	6.0	6.0
Nitrofurantoin	14	6.0	6.0
Nitrofurantoin (Monohydrate/Macrocrystals)	14	5.9	5.9
Modafinil	26	5.7	5.7
Deferasirox	21	5.6	5.6
Mycophenolic Acid	25	5.5	5.5
Cetirizine	60	5.5	5.5
Sodium Bicarbonate	18	5.5	5.5
Sodium Bicarbonate Injection,	18	5.5	5.5
Quinapril Hydrochloride	6	5.3	5.3
Tafamidis	8	4.8	4.8
Atomoxetine Hydrochloride	16	4.7	4.7
Acetaminophen And Codeine	8	4.6	4.6
Interferon Beta-1B	12	4.4	4.4
Emtricitabine And Tenofovir Alafenamide	7	4.3	4.3
Asfotase Alfa	6	4.2	4.2
Mirabegron	23	4.2	4.2
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	12	4.1	4.1
Naproxen Sodium, Pseudoephedrine Hydrochloride	12	4.1	4.1
Busulfan	9	4.0	4.0
Tolvaptan	8	3.9	3.9
Etonogestrel And Ethinyl Estradiol	12	3.8	3.8
Niraparib	12	3.8	3.8
Teduglutide	7	3.6	3.6
Dronedarone	5	3.4	3.4
Dapagliflozin	15	3.4	3.4
Canagliflozin	14	3.3	3.3
Voclosporin	4	3.2	3.2
Buprenorphine Hydrochloride, Naloxone Hydrochloride	11	3.2	3.2
Sevelamer Carbonate	5	3.1	3.1
Agalsidase Beta	4	3.0	3.0
Teriflunomide	19	3.0	3.0
Ocrelizumab	21	2.4	2.4
Rucaparib	3	2.4	2.4
Orlistat	8	2.2	2.2
Teriparatide	34	2.1	2.1
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	3	2.1	2.1
Abaloparatide	7	1.7	1.7
Tapentadol Hydrochloride	7	1.5	1.5
Minoxidil Foam 5% (Womens)	6	1.3	1.3
Esketamine Hydrochloride	3	1.2	1.2
Copper	5	0.8	0.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.